Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |